Ixabiso elifanelekileyo le-China Medical Neutrophil Gelatinase-Associated Lipocalin (NGAL) Kit Rapid Test Kit Medical Urine Reagent

inkcazo emfutshane:


  • Ixesha lovavanyo:imizuzu eli-10-15
  • Ixesha Elisebenzayo:Iinyanga ezingama-24
  • Ukuchaneka:Ngaphezulu kwe-99%
  • Inkcazo:Uvavanyo/ibhokisi eyi-1/25
  • Ubushushu bokugcina:2℃ -30℃
  • :
  • Iinkcukacha zeMveliso

    Iithegi zeMveliso

    Siqhubeka siphumeza umoya wethu "wokuvelisa izinto ezintsha, ukuqinisekisa ukuba zisemgangathweni ophezulu, umvuzo wokuthengisa kulawulo, imbali yetyala etsala abathengi ngexabiso elifanelekileyo lezonyango zaseTshayina.I-Neutrophil Gelatinase-Associated Lipocalin(NGAL) Kit Rapid Test Kit Medical Urine Reagent, Siyabamkela ngokufudumeleyo amaqabane enkampani avela kuzo zonke iinkalo zobomi bemihla ngemihla, sinethemba lokuseka umnxeba omnandi nosebenzisanayo kunye nani kwaye sifikelele usukelo oluya kuphumelela kuwo onke amaqela.
    Siqhubeka siphumeza umoya wethu "wokuvelisa izinto ezintsha, ukuqinisekisa ukuba zisemgangathweni ophezulu, umvuzo wokuthengisa kulawulo, imbali yetyala etsala abathengiIkhithi yeNgal yaseTshayina, I-Neutrophil Gelatinase-Associated Lipocalin, Inkampani yethu inamathela kumgaqo "womgangatho ophezulu, ixabiso elifanelekileyo kunye nokuhanjiswa ngexesha elifanelekileyo". Sinethemba elinyanisekileyo lokuseka ubudlelwane obuhle bentsebenziswano namaqabane ethu amatsha nawakudala oshishino avela kuzo zonke iindawo zehlabathi. Sinethemba lokusebenza nani kwaye sikukhonze ngeempahla zethu kunye neenkonzo zethu ezibalaseleyo. Wamkelekile ukuba ujoyine nathi!
    I-CEA

    cal_conew1

     

    Iimveliso Iinkcukacha ikhowudi iyunithi uluhlu oluthe tye uluhlu lwesalathiso Uluhlu olunemigca
    Ikhithi yokuxilonga i-Carcino-embryonic antigen 25T/Ibhokisi I-Cea ng/ml 2-500 5

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     


  • Ngaphambili:
  • Okulandelayo: